hotspot -WSS

hotspot

author：focus 2025-10-01 00:05:49 - browse：167

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Big Tobacco's 'harm reduction': Is it for real, or a sham?

WSS

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Sanders adds drug shortage policies to pandemic preparedness bill

Key House panel plots a new health care package

Arc Institute generative AI designs new CRISPR systems

It's time to retire 'poor historian' from clinicians' vocabularies

Startup Neumora takes a novel depression drug to Phase 3

Wikipedia

hotspot

entertainment

Walensky prepares to leave CDC — and Congress — behind

Listen: Wegovy in the brain & pivotal Alzheimer's data

Heart attack and stroke risk calculators need revising

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

What does generative AI mean for health care? We asked experts

NVIDIA and Google execs on the future of AI and drug discovery

Anesthesiologist group: stop taking Ozempic before surgery

Sanders adds drug shortage policies to pandemic preparedness bill

How one medical school became remarkably diverse

Sanders adds drug shortage policies to pandemic preparedness bill

hotspot

Startup Neumora takes a novel depression drug to Phase 3

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Group opposing PBM reform sets lobbying record

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Biden tests positive for Covid

In early work, researchers turn to CRISPR to treat Alzheimer's

explore

hotspot

Wikipedia

leisure time